What Is Iridocyclitis? Symptoms, Causes & Treatment

Iridocyclitis is inflammation of the iris and the ciliary body, the two structures at the front of the eye that control pupil size and focus. It falls under the broader category of anterior uveitis, which is the most common form of uveitis overall. The condition typically causes eye pain, light sensitivity, redness, and blurred vision, and it can be linked to autoimmune conditions elsewhere in the body.

Where It Fits Among Eye Inflammations

The uvea is the middle layer of the eye, and inflammation anywhere along it is called uveitis. When only the iris is inflamed, the diagnosis is iritis. When only the front portion of the ciliary body (the ring of tissue behind the iris that produces fluid and adjusts the lens) is involved, it’s called anterior cyclitis. When both are inflamed at the same time, the result is iridocyclitis. In everyday clinical use, doctors often use “anterior uveitis” and “iridocyclitis” almost interchangeably because the iris and ciliary body sit so close together that inflammation in one frequently spreads to the other.

Symptoms and What Causes Them

The hallmark symptoms include moderate to severe eye pain, a deep red flush around the colored part of the eye (called ciliary flush), blurry vision, watery eyes, and pupils that appear smaller than usual or irregularly shaped. Light sensitivity is particularly telling: it often occurs in both eyes even when only one is inflamed. This “consensual photophobia” happens because shining light in either eye triggers a reflex that constricts both pupils, tugging on inflamed tissue.

The pain and constricted pupils are driven by spasm of the muscles inside the ciliary body and iris. That’s why one of the first treatments is eye drops that temporarily paralyze those muscles, relaxing the spasm and relieving pain almost immediately.

Common Causes and the HLA-B27 Connection

About half of all acute anterior uveitis cases are associated with a genetic marker called HLA-B27. Carrying this gene doesn’t guarantee you’ll develop iridocyclitis, but it significantly raises the odds, especially if you also have a spondyloarthropathy, a family of inflammatory conditions that primarily affect the spine and joints. Ankylosing spondylitis has the strongest link, followed by reactive arthritis and undifferentiated spondyloarthropathy. Among people with HLA-B27 who develop acute anterior uveitis, roughly 50 to 75 percent have one of these joint conditions.

Other triggers include infections such as syphilis, tuberculosis, Lyme disease, toxoplasmosis, and herpes viruses. Certain medications can also cause it. In many cases, though, no clear cause is found, and the episode is labeled idiopathic.

How It’s Diagnosed

An eye doctor examines the front of the eye with a slit lamp, a high-powered microscope that creates a narrow beam of light through the eye’s anterior chamber (the fluid-filled space between the cornea and the iris). In iridocyclitis, this beam reveals two key signs: individual white blood cells floating in the fluid and a hazy glow called “flare” caused by protein leaking from inflamed blood vessels. Doctors grade both on a scale from 0 to 4+. A grade of 1+ means faint haziness and a handful of cells. At 4+, the chamber is so clouded with protein and fibrin that the iris details are barely visible.

These grades guide treatment intensity and help track whether the inflammation is improving or worsening over follow-up visits.

How It Differs From Conjunctivitis

Because both conditions produce a red eye, iridocyclitis is sometimes mistaken for conjunctivitis (pink eye). The differences are important. Conjunctivitis causes minimal pain, no light sensitivity, normal pupils, and often a discharge or crusting. Iridocyclitis causes deeper pain, consensual photophobia, constricted or irregular pupils, and a redness that concentrates in a ring around the iris rather than across the entire white of the eye.

A quick clue: numbing eye drops relieve the irritation of conjunctivitis but do nothing for iridocyclitis pain, because the inflammation is deeper inside the eye where topical anesthetics can’t reach.

Treatment Approach

The standard first-line treatment involves two types of eye drops. Steroid drops reduce the inflammation itself. In moderate to severe cases, these are used as frequently as every one to two hours initially, then gradually tapered as symptoms improve. Stopping steroids too quickly risks a rebound flare of inflammation, so the taper is slow and guided by slit-lamp findings at each follow-up.

The second drop is a cycloplegic agent that dilates the pupil and relaxes the ciliary muscle. This serves a dual purpose: it eases pain from muscle spasm, and it physically pulls the iris away from the lens surface to prevent the two from sticking together.

Complications to Watch For

The most concerning complication is the formation of posterior synechiae, adhesions where the back of the iris fuses to the front of the lens. Small synechiae may have little impact, but if adhesions form all the way around the pupil (a condition called seclusio pupillae), fluid can no longer flow from behind the iris into the front chamber. Pressure builds, the peripheral iris bows forward, and secondary angle-closure glaucoma develops. This is one reason prompt treatment and pupil dilation matter so much: keeping the pupil mobile prevents adhesions from forming in the first place.

Other potential complications from repeated or chronic inflammation include cataracts, persistent elevated eye pressure, and, in severe cases, damage to the retina from fluid accumulation.

Recovery and Recurrence

A single acute episode typically resolves within several weeks with appropriate treatment, though follow-up visits continue until the slit lamp shows no remaining cells or flare. The bigger concern is relapse. Research tracking patients after their first episode found a relapse rate of about 24 percent per person-year, with roughly 39 percent of patients experiencing at least one recurrence within a year and a half of their initial remission. People who carry HLA-B27 or have an underlying spondyloarthropathy tend to relapse more often.

Recurrent episodes follow the same pattern as the first: sudden onset of pain, redness, and light sensitivity, usually in one eye. Most people who’ve had iridocyclitis once learn to recognize these early warning signs quickly, which allows them to start treatment sooner and reduce the severity of subsequent flares.